118 related articles for article (PubMed ID: 9415475)
21. Cytogenetic versus DNA diagnosis in routine referrals for fragile X syndrome.
Wang Q; Green E; Barnicoat A; Garrett D; Mullarkey M; Bobrow M; Mathew CG
Lancet; 1993 Oct; 342(8878):1025-6. PubMed ID: 8105267
[TBL] [Abstract][Full Text] [Related]
22. Screening for FMR1 and FMR2 mutations in 222 individuals from Spanish special schools: identification of a case of FRAXE-associated mental retardation.
Milà M; Sànchez A; Badenas C; Brun C; Jiménez D; Villa MP; Castellví-Bel S; Estivill X
Hum Genet; 1997 Oct; 100(5-6):503-7. PubMed ID: 9341861
[TBL] [Abstract][Full Text] [Related]
23. Trinucleotide repeat expansion and human disease.
Ashley CT; Warren ST
Annu Rev Genet; 1995; 29():703-28. PubMed ID: 8825491
[TBL] [Abstract][Full Text] [Related]
24. Identification of the FRAXE fragile site in two families ascertained for X linked mental retardation.
Flynn GA; Hirst MC; Knight SJ; Macpherson JN; Barber JC; Flannery AV; Davies KE; Buckle VJ
J Med Genet; 1993 Feb; 30(2):97-100. PubMed ID: 8445629
[TBL] [Abstract][Full Text] [Related]
25. A candidate gene for mild mental handicap at the FRAXE fragile site.
Chakrabarti L; Knight SJ; Flannery AV; Davies KE
Hum Mol Genet; 1996 Feb; 5(2):275-82. PubMed ID: 8824884
[TBL] [Abstract][Full Text] [Related]
26. Trinucleotide repeat amplification and hypermethylation of a CpG island in FRAXE mental retardation.
Knight SJ; Flannery AV; Hirst MC; Campbell L; Christodoulou Z; Phelps SR; Pointon J; Middleton-Price HR; Barnicoat A; Pembrey ME
Cell; 1993 Jul; 74(1):127-34. PubMed ID: 8334699
[TBL] [Abstract][Full Text] [Related]
27. Fragile sites, chromosomal lesions, tandem repeats, and disease.
Mirceta M; Shum N; Schmidt MHM; Pearson CE
Front Genet; 2022; 13():985975. PubMed ID: 36468036
[TBL] [Abstract][Full Text] [Related]
28. The CAG repeat at the Huntington disease gene in the Portuguese population: insights into its dynamics and to the origin of the mutation.
Costa MDC; Magalhães P; Guimarães L; Maciel P; Sequeiros J; Sousa A
J Hum Genet; 2006; 51(3):189-195. PubMed ID: 16372132
[TBL] [Abstract][Full Text] [Related]
29. Stability of the FMR1 CGG repeat in a Basque sample.
Arrieta I; Gil A; Nuñez T; Telez M; Martinez B; Criado B; Lostao C
Hum Biol; 1999 Feb; 71(1):55-68. PubMed ID: 9972098
[TBL] [Abstract][Full Text] [Related]
30. The fragile X syndrome.
de Vries BB; Halley DJ; Oostra BA; Niermeijer MF
J Med Genet; 1998 Jul; 35(7):579-89. PubMed ID: 9678703
[TBL] [Abstract][Full Text] [Related]
31. Sequence analysis of the fragile X trinucleotide repeat: implications for the origin of the fragile X mutation.
Snow K; Tester DJ; Kruckeberg KE; Schaid DJ; Thibodeau SN
Hum Mol Genet; 1994 Sep; 3(9):1543-51. PubMed ID: 7833909
[TBL] [Abstract][Full Text] [Related]
32. Evidence for two preferred hairpin folding patterns in d(CGG).d(CCG) repeat tracts in vivo.
Darlow JM; Leach DR
J Mol Biol; 1998 Jan; 275(1):17-23. PubMed ID: 9451435
[TBL] [Abstract][Full Text] [Related]
33. FRA10B structure reveals common elements in repeat expansion and chromosomal fragile site genesis.
Hewett DR; Handt O; Hobson L; Mangelsdorf M; Eyre HJ; Baker E; Sutherland GR; Schuffenhauer S; Mao JI; Richards RI
Mol Cell; 1998 May; 1(6):773-81. PubMed ID: 9660961
[TBL] [Abstract][Full Text] [Related]
34. Distribution of trinucleotide repeat sequences across a 2 Mbp region containing the Huntington's disease gene.
Hummerich H; Baxendale S; Mott R; Kirby SF; MacDonald ME; Gusella J; Lehrach H; Bates GP
Hum Mol Genet; 1994 Jan; 3(1):73-8. PubMed ID: 8162055
[TBL] [Abstract][Full Text] [Related]
35. Long CCG triplet repeat blocks exclude nucleosomes: a possible mechanism for the nature of fragile sites in chromosomes.
Wang YH; Gellibolian R; Shimizu M; Wells RD; Griffith J
J Mol Biol; 1996 Nov; 263(4):511-6. PubMed ID: 8918933
[TBL] [Abstract][Full Text] [Related]
36. FRAXE mutation in mentally retarded patients using the OxE18 probe.
Mulatinho MV; Llerena JC; Pimentel MM
Int J Mol Med; 2000 Jan; 5(1):67-9. PubMed ID: 10601577
[TBL] [Abstract][Full Text] [Related]
37. PCR approach for detection of Fragile X syndrome and Huntington disease based on modified DNA: limits and utility.
Rosales-Reynoso MA; Vilatela EA; Ojeda RM; Arce-Rivas A; Sandoval L; Troyo-Sanromán R; Barros-Núñez P
Genet Test; 2007; 11(2):153-9. PubMed ID: 17627386
[TBL] [Abstract][Full Text] [Related]
38. Mapping of an origin of DNA replication in the promoter of fragile X gene FMR1.
Brylawski BP; Chastain PD; Cohen SM; Cordeiro-Stone M; Kaufman DG
Exp Mol Pathol; 2007 Apr; 82(2):190-6. PubMed ID: 17196195
[TBL] [Abstract][Full Text] [Related]
39. Linkage disequilibrium between the expanded (CAG)n repeat and an allele of the adjacent (CCG)n repeat in Huntington's disease patients of Greek origin.
Yapijakis C; Vassilopoulos D; Tzagournisakis M; Maris T; Fesdjian C; Papageorgiou C; Plaitakis A
Eur J Hum Genet; 1995; 3(4):228-34. PubMed ID: 8528671
[TBL] [Abstract][Full Text] [Related]
40. Microsatellite and trinucleotide-repeat evolution: evidence for mutational bias and different rates of evolution in different lineages.
Rubinsztein DC; Amos B; Cooper G
Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):1095-9. PubMed ID: 10434312
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
